The Role of Nitric Oxide in Cognition in Schizophrenia
Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the role of the Nitric Oxide system in cognition in patients with
schizophrenia. Participants will be randomised to 2 equal groups and receive either the
Nitric Oxide donor molecule glyceryl trinitrate, or a placebo. Performance on several
cognitive tasks will be assessed.